VentriPoint Diagnostics Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VPTDF research report →
Companywww.ventripoint.com
Ventripoint Diagnostics Ltd. , a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction.
- CEO
- Hugh MacNaught
- IPO
- 2010
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $20.87M
- P/E
- -7.93
- P/S
- 156.45
- P/B
- -6.17
- EV/EBITDA
- -9.23
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 82.94%
- Op Margin
- -1889.37%
- Net Margin
- -1778.62%
- ROE
- 78.25%
- ROIC
- 220.77%
Growth & Income
- Revenue
- $179.78K · 88.90%
- Net Income
- $-3,197,633 · 35.00%
- EPS
- $-0.02 · 37.94%
- Op Income
- $-3,396,732
- FCF YoY
- 54.12%
Performance & Tape
- 52W High
- $0.14
- 52W Low
- $0.06
- 50D MA
- $0.09
- 200D MA
- $0.08
- Beta
- -0.04
- Avg Volume
- 100.77K
Get TickerSpark's AI analysis on VPTDF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our VPTDF Coverage
We haven't published any research on VPTDF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VPTDF Report →